Inhibition of the local Shwartzman reaction by dicumarol. 1955

S SPANOUDIS, and F EICHBAUM, and G ROSENFELD

UI MeSH Term Description Entries
D006967 Hypersensitivity Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen. Allergy,Allergic Reaction,Allergic Reactions,Allergies,Hypersensitivities,Reaction, Allergic,Reactions, Allergic
D007154 Immune System Diseases Disorders caused by abnormal or absent immunologic mechanisms, whether humoral, cell-mediated, or both. Immune Disorders,Immune System Disorders,Immunologic Diseases,Diseases of Immune System,Immune Diseases,Immunological Diseases,Disease, Immune,Disease, Immune System,Disease, Immunologic,Disease, Immunological,Disorder, Immune System,Immune Disease,Immune Disorder,Immune System Disease,Immune System Disorder,Immunologic Disease,Immunological Disease
D001728 Dicumarol An oral anticoagulant that interferes with the metabolism of vitamin K. It is also used in biochemical experiments as an inhibitor of reductases. Bishydroxycoumarin,Dicoumarin,Dicoumarol
D003374 Coumarins Synthetic or naturally occurring substances related to coumarin, the delta-lactone of coumarinic acid. 1,2-Benzopyrone Derivatives,1,2-Benzopyrones,Coumarin Derivative,Coumarine,1,2-Benzo-Pyrones,Benzopyran-2-ones,Coumarin Derivatives,Coumarines,1,2 Benzo Pyrones,1,2 Benzopyrone Derivatives,1,2 Benzopyrones,Benzopyran 2 ones,Derivative, Coumarin,Derivatives, 1,2-Benzopyrone,Derivatives, Coumarin
D012790 Shwartzman Phenomenon Hemorrhagic necrosis that was first demonstrated in rabbits with a two-step reaction, an initial local (intradermal) or general (intravenous) injection of a priming endotoxin (ENDOTOXINS) followed by a second intravenous endotoxin injection (provoking agent) 24 h later. The acute inflammation damages the small blood vessels. The following intravascular coagulation leads to capillary and venous THROMBOSIS and NECROSIS. Shwartzman phenomenon can also occur in other species with a single injection of a provoking agent, and during infections or pregnancy. Its susceptibility depends on the status of IMMUNE SYSTEM, coagulation, FIBRINOLYSIS, and blood flow. Schwartzman Phenomenon,Shwartzman Reaction,Schwartzman Reaction,Phenomenon, Schwartzman,Phenomenon, Shwartzman,Schwartzman Reactions

Related Publications

S SPANOUDIS, and F EICHBAUM, and G ROSENFELD
May 1953, Bulletin of the Johns Hopkins Hospital,
S SPANOUDIS, and F EICHBAUM, and G ROSENFELD
October 1954, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
S SPANOUDIS, and F EICHBAUM, and G ROSENFELD
February 1975, Experientia,
S SPANOUDIS, and F EICHBAUM, and G ROSENFELD
September 1957, The Journal of allergy,
S SPANOUDIS, and F EICHBAUM, and G ROSENFELD
January 1978, Vox sanguinis,
S SPANOUDIS, and F EICHBAUM, and G ROSENFELD
November 1972, Blood,
S SPANOUDIS, and F EICHBAUM, and G ROSENFELD
December 1952, Journal of immunology (Baltimore, Md. : 1950),
S SPANOUDIS, and F EICHBAUM, and G ROSENFELD
February 1964, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
S SPANOUDIS, and F EICHBAUM, and G ROSENFELD
May 1970, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
S SPANOUDIS, and F EICHBAUM, and G ROSENFELD
January 1973, Acta medica Academiae Scientiarum Hungaricae,
Copied contents to your clipboard!